BioInvent and Cancer Research Technology enter Oncology collaboration
Therapeutics Daily
Barts and The London School of Medicine and Dentistry (Barts Cancer Institute): Dr Thorsten Hagemann
BioInvent and Cancer Research Technology enter Oncology collaboration
Therapeutics Daily
BioInvent International AB and Cancer Research Technology Ltd, the commercial arm of Cancer Research UK, have announced a collaboration with Queen Mary to identify new oncology therapies. The research team will be led by Cancer Research UK scientist Dr Thorsten Hagemann, who says: “By combining the preclinical expertise in animal models within my laboratory and our access to patient samples with BioInvent's F.I.R.S.T.™ technology we hope to speed up the discovery and development of new possible treatments.”